Published: January 2023 | Report Code: 10542 | Available Format: PDF | Pages: 330
Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by component
1.4.2. Market size breakdown, by delivery mode
1.4.3. Market size breakdown, by application
1.4.4. Market size breakdown, by therapeutic area
1.4.5. Market size breakdown, by end user
1.4.6. Market size breakdown, by region
1.4.7. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Component (2017–2030)
7.2.1. Software market revenue, by type (2017–2030)
7.2.2. Services market revenue, by type (2017–2030)
7.3. Market Revenue, by Delivery Mode (2017–2030)
7.4. Market Revenue, by Application (2017–2030)
7.5. Market Revenue, by Therapeutic Area (2017–2030)
7.5.1. Chronic diseases market revenue, by type (2017–2030)
7.6. Market Revenue, by End User (2017–2030)
7.7. Market Revenue, by Region (2017–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Component (2017–2030)
8.2.1. Software market revenue, by type (2017–2030)
8.2.2. Services market revenue, by type (2017–2030)
8.3. Market Revenue, by Delivery Mode (2017–2030)
8.4. Market Revenue, by Application (2017–2030)
8.5. Market Revenue, by Therapeutic Area (2017–2030)
8.5.1. Chronic diseases market revenue, by type (2017–2030)
8.6. Market Revenue, by End User (2017–2030)
8.7. Market Revenue, by Country (2017–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Component (2017–2030)
9.2.1. Software market revenue, by type (2017–2030)
9.2.2. Services market revenue, by type (2017–2030)
9.3. Market Revenue, by Delivery Mode (2017–2030)
9.4. Market Revenue, by Application (2017–2030)
9.5. Market Revenue, by Therapeutic Area (2017–2030)
9.5.1. Chronic diseases market revenue, by type (2017–2030)
9.6. Market Revenue, by End User (2017–2030)
9.7. Market Revenue, by Country (2017–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Component (2017–2030)
10.2.1. Software market revenue, by type (2017–2030)
10.2.2. Services market revenue, by type (2017–2030)
10.3. Market Revenue, by Delivery Mode (2017–2030)
10.4. Market Revenue, by Application (2017–2030)
10.5. Market Revenue, by Therapeutic Area (2017–2030)
10.5.1. Chronic diseases market revenue, by type (2017–2030)
10.6. Market Revenue, by End User (2017–2030)
10.7. Market Revenue, by Country (2017–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Component (2017–2030)
11.2.1. Software market revenue, by type (2017–2030)
11.2.2. Services market revenue, by type (2017–2030)
11.3. Market Revenue, by Delivery Mode (2017–2030)
11.4. Market Revenue, by Application (2017–2030)
11.5. Market Revenue, by Therapeutic Area (2017–2030)
11.5.1. Chronic diseases market revenue, by type (2017–2030)
11.6. Market Revenue, by End User (2017–2030)
11.7. Market Revenue, by Country (2017–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Component (2017–2030)
12.2.1. Software market revenue, by type (2017–2030)
12.2.2. Services market revenue, by type (2017–2030)
12.3. Market Revenue, by Delivery Mode (2017–2030)
12.4. Market Revenue, by Application (2017–2030)
12.5. Market Revenue, by Therapeutic Area (2017–2030)
12.5.1. Chronic diseases market revenue, by type (2017–2030)
12.6. Market Revenue, by End User (2017–2030)
12.7. Market Revenue, by Country (2017–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Component (2017–2030)
13.2.1. Software market revenue, by type (2017–2030)
13.2.2. Services market revenue, by type (2017–2030)
13.3. Market Revenue, by Delivery Mode (2017–2030)
13.4. Market Revenue, by Application (2017–2030)
13.5. Market Revenue, by Therapeutic Area (2017–2030)
13.5.1. Chronic diseases market revenue, by type (2017–2030)
13.6. Market Revenue, by End User (2017–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Component (2017–2030)
14.2.1. Software market revenue, by type (2017–2030)
14.2.2. Services market revenue, by type (2017–2030)
14.3. Market Revenue, by Delivery Mode (2017–2030)
14.4. Market Revenue, by Application (2017–2030)
14.5. Market Revenue, by Therapeutic Area (2017–2030)
14.5.1. Chronic diseases market revenue, by type (2017–2030)
14.6. Market Revenue, by End User (2017–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Component (2017–2030)
15.2.1. Software market revenue, by type (2017–2030)
15.2.2. Services market revenue, by type (2017–2030)
15.3. Market Revenue, by Delivery Mode (2017–2030)
15.4. Market Revenue, by Application (2017–2030)
15.5. Market Revenue, by Therapeutic Area (2017–2030)
15.5.1. Chronic diseases market revenue, by type (2017–2030)
15.6. Market Revenue, by End User (2017–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Component (2017–2030)
16.2.1. Software market revenue, by type (2017–2030)
16.2.2. Services market revenue, by type (2017–2030)
16.3. Market Revenue, by Delivery Mode (2017–2030)
16.4. Market Revenue, by Application (2017–2030)
16.5. Market Revenue, by Therapeutic Area (2017–2030)
16.5.1. Chronic diseases market revenue, by type (2017–2030)
16.6. Market Revenue, by End User (2017–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Component (2017–2030)
17.2.1. Software market revenue, by type (2017–2030)
17.2.2. Services market revenue, by type (2017–2030)
17.3. Market Revenue, by Delivery Mode (2017–2030)
17.4. Market Revenue, by Application (2017–2030)
17.5. Market Revenue, by Therapeutic Area (2017–2030)
17.5.1. Chronic diseases market revenue, by type (2017–2030)
17.6. Market Revenue, by End User (2017–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Component (2017–2030)
18.2.1. Software market revenue, by type (2017–2030)
18.2.2. Services market revenue, by type (2017–2030)
18.3. Market Revenue, by Delivery Mode (2017–2030)
18.4. Market Revenue, by Application (2017–2030)
18.5. Market Revenue, by Therapeutic Area (2017–2030)
18.5.1. Chronic diseases market revenue, by type (2017–2030)
18.6. Market Revenue, by End User (2017–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Component (2017–2030)
19.2.1. Software market revenue, by type (2017–2030)
19.2.2. Services market revenue, by type (2017–2030)
19.3. Market Revenue, by Delivery Mode (2017–2030)
19.4. Market Revenue, by Application (2017–2030)
19.5. Market Revenue, by Therapeutic Area (2017–2030)
19.5.1. Chronic diseases market revenue, by type (2017–2030)
19.6. Market Revenue, by End User (2017–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Component (2017–2030)
20.2.1. Software market revenue, by type (2017–2030)
20.2.2. Services market revenue, by type (2017–2030)
20.3. Market Revenue, by Delivery Mode (2017–2030)
20.4. Market Revenue, by Application (2017–2030)
20.5. Market Revenue, by Therapeutic Area (2017–2030)
20.5.1. Chronic diseases market revenue, by type (2017–2030)
20.6. Market Revenue, by End User (2017–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Component (2017–2030)
21.2.1. Software market revenue, by type (2017–2030)
21.2.2. Services market revenue, by type (2017–2030)
21.3. Market Revenue, by Delivery Mode (2017–2030)
21.4. Market Revenue, by Application (2017–2030)
21.5. Market Revenue, by Therapeutic Area (2017–2030)
21.5.1. Chronic diseases market revenue, by type (2017–2030)
21.6. Market Revenue, by End User (2017–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Component (2017–2030)
22.2.1. Software market revenue, by type (2017–2030)
22.2.2. Services market revenue, by type (2017–2030)
22.3. Market Revenue, by Delivery Mode (2017–2030)
22.4. Market Revenue, by Application (2017–2030)
22.5. Market Revenue, by Therapeutic Area (2017–2030)
22.5.1. Chronic diseases market revenue, by type (2017–2030)
22.6. Market Revenue, by End User (2017–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Component (2017–2030)
23.2.1. Software market revenue, by type (2017–2030)
23.2.2. Services market revenue, by type (2017–2030)
23.3. Market Revenue, by Delivery Mode (2017–2030)
23.4. Market Revenue, by Application (2017–2030)
23.5. Market Revenue, by Therapeutic Area (2017–2030)
23.5.1. Chronic diseases market revenue, by type (2017–2030)
23.6. Market Revenue, by End User (2017–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Component (2017–2030)
24.2.1. Software market revenue, by type (2017–2030)
24.2.2. Services market revenue, by type (2017–2030)
24.3. Market Revenue, by Delivery Mode (2017–2030)
24.4. Market Revenue, by Application (2017–2030)
24.5. Market Revenue, by Therapeutic Area (2017–2030)
24.5.1. Chronic diseases market revenue, by type (2017–2030)
24.6. Market Revenue, by End User (2017–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Component (2017–2030)
25.2.1. Software market revenue, by type (2017–2030)
25.2.2. Services market revenue, by type (2017–2030)
25.3. Market Revenue, by Delivery Mode (2017–2030)
25.4. Market Revenue, by Application (2017–2030)
25.5. Market Revenue, by Therapeutic Area (2017–2030)
25.5.1. Chronic diseases market revenue, by type (2017–2030)
25.6. Market Revenue, by End User (2017–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Component (2017–2030)
26.2.1. Software market revenue, by type (2017–2030)
26.2.2. Services market revenue, by type (2017–2030)
26.3. Market Revenue, by Delivery Mode (2017–2030)
26.4. Market Revenue, by Application (2017–2030)
26.5. Market Revenue, by Therapeutic Area (2017–2030)
26.5.1. Chronic diseases market revenue, by type (2017–2030)
26.6. Market Revenue, by End User (2017–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Component (2017–2030)
27.2.1. Software market revenue, by type (2017–2030)
27.2.2. Services market revenue, by type (2017–2030)
27.3. Market Revenue, by Delivery Mode (2017–2030)
27.4. Market Revenue, by Application (2017–2030)
27.5. Market Revenue, by Therapeutic Area (2017–2030)
27.5.1. Chronic diseases market revenue, by type (2017–2030)
27.6. Market Revenue, by End User (2017–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Component (2017–2030)
28.2.1. Software market revenue, by type (2017–2030)
28.2.2. Services market revenue, by type (2017–2030)
28.3. Market Revenue, by Delivery Mode (2017–2030)
28.4. Market Revenue, by Application (2017–2030)
28.5. Market Revenue, by Therapeutic Area (2017–2030)
28.5.1. Chronic diseases market revenue, by type (2017–2030)
28.6. Market Revenue, by End User (2017–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Component (2017–2030)
29.2.1. Software market revenue, by type (2017–2030)
29.2.2. Services market revenue, by type (2017–2030)
29.3. Market Revenue, by Delivery Mode (2017–2030)
29.4. Market Revenue, by Application (2017–2030)
29.5. Market Revenue, by Therapeutic Area (2017–2030)
29.5.1. Chronic diseases market revenue, by type (2017–2030)
29.6. Market Revenue, by End User (2017–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. McKesson Corporation
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. Cerner Corporation
31.2.1. Business overview
31.2.2. Product and service offerings
31.2.3. Key financial summary
31.3. Epic Systems Corporation
31.3.1. Business overview
31.3.2. Product and service offerings
31.4. Orion Health
31.4.1. Business overview
31.4.2. Product and service offerings
31.5. Oneview Healthcare PLC
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. GetWellNetwork Inc.
31.6.1. Business overview
31.6.2. Product and service offerings
31.7. Wolters Kluwer N.V.
31.7.1. Business overview
31.7.2. Product and service offerings
31.7.3. Key financial summary
31.8. Klara Technologies Inc.
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. Allscripts Healthcare LLC
31.9.1. Business overview
31.9.2. Product and service offerings
31.9.3. Key financial summary
31.10. Greenway Health LLC
31.10.1. Business overview
31.10.2. Product and service offerings
31.11. athenahealth Inc.
31.11.1. Business overview
31.11.2. Product and service offerings
31.11.3. Key financial summary
31.12. International Business Machines Corporation
31.12.1. Business overview
31.12.2. Product and service offerings
31.12.3. Key financial summary
31.13. Medecision Inc.
31.13.1. Business overview
31.13.2. Product and service offerings
31.14. Lincor Inc.
31.14.1. Business overview
31.14.2. Product and service offerings
31.15. Force Therapeutics
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 5 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 6 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 7 GLOBAL PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 8 GLOBAL PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 9 GLOBAL PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 10 GLOBAL PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 11 GLOBAL PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 12 GLOBAL PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 13 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 14 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 15 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 16 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 17 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 18 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 19 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 20 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 21 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 22 GLOBAL CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 23 GLOBAL CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 24 GLOBAL CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 25 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 26 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 27 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 28 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, $M (2017–2022)
TABLE 29 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, $M (2023–2026)
TABLE 30 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, $M (2027–2030)
TABLE 31 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 32 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 33 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 34 NORTH AMERICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 35 NORTH AMERICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 36 NORTH AMERICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 37 NORTH AMERICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 38 NORTH AMERICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 39 NORTH AMERICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 40 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 41 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 42 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 43 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 44 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 45 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 46 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 47 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 48 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 49 NORTH AMERICA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 50 NORTH AMERICA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 51 NORTH AMERICA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 52 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 53 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 54 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 55 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2022)
TABLE 56 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2023–2026)
TABLE 57 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2027–2030)
TABLE 58 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 59 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 60 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 61 EUROPE PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 62 EUROPE PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 63 EUROPE PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 64 EUROPE PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 65 EUROPE PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 66 EUROPE PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 67 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 68 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 69 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 70 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 71 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 72 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 73 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 74 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 75 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 76 EUROPE CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 77 EUROPE CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 78 EUROPE CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 79 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 80 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 81 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 82 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2022)
TABLE 83 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2023–2026)
TABLE 84 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2027–2030)
TABLE 85 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 86 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 87 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 88 APAC PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 89 APAC PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 90 APAC PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 91 APAC PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 92 APAC PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 93 APAC PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 94 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 95 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 96 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 97 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 98 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 99 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 100 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 101 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 102 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 103 APAC CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 104 APAC CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 105 APAC CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 106 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 107 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 108 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 109 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2022)
TABLE 110 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2023–2026)
TABLE 111 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2027–2030)
TABLE 112 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 113 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 114 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 115 LATAM PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 116 LATAM PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 117 LATAM PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 118 LATAM PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 119 LATAM PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 120 LATAM PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 121 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 122 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 123 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 124 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 125 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 126 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 127 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 128 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 129 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 130 LATAM CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 131 LATAM CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 132 LATAM CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 133 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 134 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 135 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 136 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2022)
TABLE 137 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2023–2026)
TABLE 138 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2027–2030)
TABLE 139 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 140 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 141 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 142 MEA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 143 MEA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 144 MEA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 145 MEA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 146 MEA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 147 MEA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 148 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 149 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 150 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 151 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 152 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 153 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 154 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 155 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 156 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 157 MEA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 158 MEA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 159 MEA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 160 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 161 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 162 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 163 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2022)
TABLE 164 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2023–2026)
TABLE 165 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2027–2030)
TABLE 166 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 167 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 168 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 169 U.S. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 170 U.S. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 171 U.S. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 172 U.S. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 173 U.S. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 174 U.S. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 175 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 176 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 177 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 178 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 179 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 180 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 181 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 182 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 183 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 184 U.S. CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 185 U.S. CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 186 U.S. CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 187 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 188 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 189 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 190 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 191 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 192 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 193 CANADA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 194 CANADA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 195 CANADA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 196 CANADA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 197 CANADA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 198 CANADA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 199 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 200 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 201 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 202 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 203 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 204 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 205 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 206 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 207 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 208 CANADA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 209 CANADA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 210 CANADA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 211 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 212 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 213 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 214 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 215 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 216 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 217 GERMANY PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 218 GERMANY PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 219 GERMANY PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 220 GERMANY PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 221 GERMANY PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 222 GERMANY PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 223 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 224 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 225 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 226 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 227 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 228 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 229 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 230 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 231 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 232 GERMANY CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 233 GERMANY CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 234 GERMANY CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 235 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 236 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 237 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 238 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 239 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 240 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 241 FRANCE PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 242 FRANCE PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 243 FRANCE PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 244 FRANCE PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 245 FRANCE PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 246 FRANCE PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 247 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 248 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 249 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 250 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 251 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 252 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 253 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 254 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 255 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 256 FRANCE CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 257 FRANCE CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 258 FRANCE CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 259 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 260 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 261 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 262 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 263 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 264 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 265 U.K. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 266 U.K. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 267 U.K. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 268 U.K. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 269 U.K. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 270 U.K. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 271 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 272 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 273 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 274 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 275 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 276 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 277 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 278 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 279 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 280 U.K. CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 281 U.K. CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 282 U.K. CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 283 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 284 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 285 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 286 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 287 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 288 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 289 ITALY PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 290 ITALY PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 291 ITALY PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 292 ITALY PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 293 ITALY PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 294 ITALY PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 295 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 296 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 297 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 298 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 299 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 300 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 301 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 302 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 303 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 304 ITALY CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 305 ITALY CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 306 ITALY CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 307 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 308 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 309 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 310 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 311 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 312 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 313 SPAIN PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 314 SPAIN PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 315 SPAIN PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 316 SPAIN PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 317 SPAIN PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 318 SPAIN PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 319 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 320 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 321 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 322 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 323 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 324 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 325 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 326 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 327 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 328 SPAIN CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 329 SPAIN CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 330 SPAIN CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 331 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 332 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 333 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 334 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 335 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 336 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 337 JAPAN PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 338 JAPAN PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 339 JAPAN PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 340 JAPAN PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 341 JAPAN PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 342 JAPAN PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 343 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 344 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 345 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 346 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 347 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 348 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 349 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 350 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 351 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 352 JAPAN CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 353 JAPAN CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 354 JAPAN CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 355 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 356 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 357 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 358 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 359 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 360 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 361 CHINA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 362 CHINA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 363 CHINA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 364 CHINA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 365 CHINA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 366 CHINA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 367 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 368 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 369 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 370 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 371 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 372 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 373 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 374 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 375 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 376 CHINA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 377 CHINA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 378 CHINA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 379 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 380 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 381 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 382 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 383 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 384 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 385 INDIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 386 INDIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 387 INDIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 388 INDIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 389 INDIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 390 INDIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 391 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 392 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 393 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 394 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 395 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 396 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 397 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 398 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 399 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 400 INDIA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 401 INDIA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 402 INDIA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 403 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 404 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 405 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 406 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 407 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 408 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 409 AUSTRALIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 410 AUSTRALIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 411 AUSTRALIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 412 AUSTRALIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 413 AUSTRALIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 414 AUSTRALIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 415 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 416 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 417 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 418 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 419 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 420 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 421 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 422 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 423 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 424 AUSTRALIA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 425 AUSTRALIA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 426 AUSTRALIA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 427 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 428 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 429 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 430 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 431 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 432 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 433 SOUTH KOREA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 434 SOUTH KOREA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 435 SOUTH KOREA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 436 SOUTH KOREA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 437 SOUTH KOREA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 438 SOUTH KOREA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 439 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 440 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 441 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 442 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 443 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 444 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 445 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 446 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 447 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 448 SOUTH KOREA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 449 SOUTH KOREA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 450 SOUTH KOREA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 451 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 452 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 453 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 454 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 455 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 456 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 457 BRAZIL PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 458 BRAZIL PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 459 BRAZIL PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 460 BRAZIL PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 461 BRAZIL PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 462 BRAZIL PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 463 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 464 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 465 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 466 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 467 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 468 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 469 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 470 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 471 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 472 BRAZIL CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 473 BRAZIL CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 474 BRAZIL CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 475 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 476 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 477 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 478 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 479 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 480 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 481 MEXICO PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 482 MEXICO PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 483 MEXICO PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 484 MEXICO PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 485 MEXICO PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 486 MEXICO PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 487 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 488 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 489 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 490 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 491 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 492 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 493 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 494 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 495 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 496 MEXICO CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 497 MEXICO CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 498 MEXICO CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 499 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 500 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 501 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 502 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 503 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 504 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 505 SAUDI ARABIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 506 SAUDI ARABIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 507 SAUDI ARABIA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 508 SAUDI ARABIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 509 SAUDI ARABIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 510 SAUDI ARABIA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 511 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 512 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 513 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 514 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 515 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 516 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 517 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 518 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 519 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 520 SAUDI ARABIA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 521 SAUDI ARABIA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 522 SAUDI ARABIA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 523 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 524 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 525 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 526 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 527 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 528 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 529 SOUTH AFRICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 530 SOUTH AFRICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 531 SOUTH AFRICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 532 SOUTH AFRICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 533 SOUTH AFRICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 534 SOUTH AFRICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 535 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 536 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 537 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 538 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 539 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 540 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 541 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 542 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 543 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 544 SOUTH AFRICA CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 545 SOUTH AFRICA CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 546 SOUTH AFRICA CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 547 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 548 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 549 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 550 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2022)
TABLE 551 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2023–2026)
TABLE 552 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2027–2030)
TABLE 553 U.A.E. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2017–2022)
TABLE 554 U.A.E. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2023–2026)
TABLE 555 U.A.E. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2027–2030)
TABLE 556 U.A.E. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2017–2022)
TABLE 557 U.A.E. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2023–2026)
TABLE 558 U.A.E. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2027–2030)
TABLE 559 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2022)
TABLE 560 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2023–2026)
TABLE 561 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2027–2030)
TABLE 562 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2022)
TABLE 563 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2023–2026)
TABLE 564 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2027–2030)
TABLE 565 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2022)
TABLE 566 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2023–2026)
TABLE 567 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2027–2030)
TABLE 568 U.A.E. CHRONIC DISEASES MARKET, BY TYPE, $M (2017–2022)
TABLE 569 U.A.E. CHRONIC DISEASES MARKET, BY TYPE, $M (2023–2026)
TABLE 570 U.A.E. CHRONIC DISEASES MARKET, BY TYPE, $M (2027–2030)
TABLE 571 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2022)
TABLE 572 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2023–2026)
TABLE 573 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2027–2030)
TABLE 574 MCKESSON CORPORATION – AT A GLANCE
TABLE 575 MCKESSON CORPORATION – KEY FINANCIAL SUMMARY
TABLE 576 CERNER CORPORATION – AT A GLANCE
TABLE 577 CERNER CORPORATION – KEY FINANCIAL SUMMARY
TABLE 578 EPIC SYSTEMS CORPORATION – AT A GLANCE
TABLE 579 ORION HEALTH – AT A GLANCE
TABLE 580 ONEVIEW HEALTHCARE PLC – AT A GLANCE
TABLE 581 ONEVIEW HEALTHCARE PLC – KEY FINANCIAL SUMMARY
TABLE 582 GETWELLNETWORK INC. – AT A GLANCE
TABLE 583 WOLTERS KLUWER N.V. – AT A GLANCE
TABLE 584 WOLTERS KLUWER N.V. – KEY FINANCIAL SUMMARY
TABLE 585 KLARA TECHNOLOGIES INC. – AT A GLANCE
TABLE 586 ALLSCRIPTS HEALTHCARE LLC – AT A GLANCE
TABLE 587 ALLSCRIPTS HEALTHCARE LLC – KEY FINANCIAL SUMMARY
TABLE 588 GREENWAY HEALTH LLC – AT A GLANCE
TABLE 589 ATHENAHEALTH INC. – AT A GLANCE
TABLE 590 ATHENAHEALTH INC. – KEY FINANCIAL SUMMARY
TABLE 591 INTERNATIONAL BUSINESS MACHINES CORPORATION – AT A GLANCE
TABLE 592 INTERNATIONAL BUSINESS MACHINES CORPORATION – KEY FINANCIAL SUMMARY
TABLE 593 MEDECISION INC. – AT A GLANCE
TABLE 594 LINCOR INC. – AT A GLANCE
TABLE 595 FORCE THERAPEUTICS – AT A GLANCE
LIST OF FIGURES
FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)
FIG 8 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 THREAT OF NEW ENTRANTS
FIG 12 INTENSITY OF RIVALRY
FIG 13 THREAT OF SUBSTITUTES
FIG 14 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIG 15 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 16 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 17 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 18 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 19 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 20 MAJOR WORLDWIDE MARKETS FOR PATIENT ENGAGEMENT SOLUTIONS, $M
FIG 21 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIG 22 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 23 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 24 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 25 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 26 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 27 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2030)
FIG 28 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIG 29 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 30 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 31 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 32 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 33 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 34 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2030)
FIG 35 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIG 36 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 37 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 38 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 39 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 40 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 41 APAC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2030)
FIG 42 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIG 43 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 44 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 45 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 46 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 47 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 48 LATAM PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2030)
FIG 49 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIG 50 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 51 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 52 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 53 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 54 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 55 MEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2017–2030)
FIG 56 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 57 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 58 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 59 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 60 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 61 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 62 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 63 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 64 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 65 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 66 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 67 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 68 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 69 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 70 GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 71 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 72 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 73 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 74 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 75 FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 76 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 77 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 78 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 79 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 80 U.K. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 81 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 82 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 83 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 84 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 85 ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 86 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 87 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 88 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 89 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 90 SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 91 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 92 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 93 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 94 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 95 JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 96 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 97 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 98 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 99 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 100 CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 101 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 102 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 103 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 104 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 105 INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 106 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 107 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 108 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 109 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 110 AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 111 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 112 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 113 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 114 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 115 SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 116 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 117 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 118 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 119 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 120 BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 121 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 122 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 123 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 124 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 125 MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 126 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 127 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 128 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 129 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 130 SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 131 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 132 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 133 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 134 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 135 SOUTH AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 136 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2017–2030)
FIG 137 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2017–2030)
FIG 138 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2017–2030)
FIG 139 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2017–2030)
FIG 140 U.A.E. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2017–2030)
FIG 141 MCKESSON CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 142 CERNER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 143 ONEVIEW HEALTHCARE PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 144 WOLTERS KLUWER N.V. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 145 ALLSCRIPTS HEALTHCARE LLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 146 ATHENAHEALTH INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 147 INTERNATIONAL BUSINESS MACHINES CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws